IMMUCOR INC
IMMUCOR INC (BLUD): 4 pipeline candidates · ~19 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
18.7 months
D/E 4.46 · 0% dilution
Lead: Approved
4 candidates
N/A
N/A
A transparent, data-derived signal for IMMUCOR INCacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
—
Cash
$10.0M
Quarterly Burn
$7.5M
Runway
18.7 mo
Revenue
$94.0M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (4 candidates)
| Drug | Phase |
|---|---|
| ksort | Approved |
| mia fora ngs | Approved |
| precisetype | Approved |
| precisetype hea | Approved |
Frequently asked questions
How many drug candidates are in IMMUCOR INC's pipeline?
IMMUCOR INC (BLUD) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is IMMUCOR INC's lead drug candidate?
IMMUCOR INC's most advanced tracked candidate is ksort (Approved) for Predict organ rejection and graft injury in kidney recipients.
What is IMMUCOR INC's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, IMMUCOR INC has approximately 18.7 months of cash runway.
Get the full picture on IMMUCOR INC
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.